# Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure

> **NCT00555477** · PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 69 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** anastrozole

## Key facts

- **NCT ID:** NCT00555477
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2011-12
- **Final completion:** 2013-09
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** The study was stopped after 69 subjects were enrolled because of poor accrual.
- **Last updated:** 2014-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555477, "Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00555477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*